SEPN peer analysis
Septerna (SEPN) against its competitors: price, today's move, 1-year return and market value side by side.
SEPN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BMEA Biomea Fusion | $0.56 | -4.65% | -56.16% | – |
| GPCR Structure Therapeutics | $20.00 | 4.82% | -40.76% | – |
| KLRA Kailera Therapeutics | $13.31 | 9.37% | – | – |
| MAZE Maze Therapeutics | $34.69 | 6.64% | 7.47% | – |
| MBX MBX Biosciences | $51.35 | 5.96% | 114.90% | – |
| VTVT vTv Therapeutics | $21.74 | -9.53% | -12.76% | $95.01M |
| SEPN Septerna | $48.78 | 3.02% | 147.52% | – |
- SEPN's peers: BMEA (Biomea Fusion), GPCR (Structure Therapeutics), KLRA (Kailera Therapeutics), MAZE (Maze Therapeutics), MBX (MBX Biosciences), VTVT (vTv Therapeutics).
Updated 2026-11-07 11:55 UTC